Shankar Biswas, Yashasvi Srivastava, Ayman Hamadttu. "Comparative real-world outcomes of durvalumab plus gemcitabine/cisplatin versus pembrolizumab plus gemcitabine/cisplatin as first-line therapy for advanced biliary tract cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.19_suppl.133